In diabetes mellitus (
DM
), the kidneys are exposed to increased levels of hyperglycemia‐induced oxidative stress. Elevated amounts of reactive oxygen species (
ROS
) are believed to provoke ultrastructural changes in kidney tissue and can eventually result in
DM
late complications such as diabetic nephropathy. While it is reported that glucagon‐like peptide 1 receptors (
GLP
‐1R) are present in the kidney vasculature, the effects of
GLP
‐1 on the kidney proteome in
DM
is not well described. Thus, we set out to investigate potential effects on the proteomic level. Here the effects of
GLP
‐1R agonism using the
GLP
‐1 analogue liraglutide are studied in the kidneys of streptozotocin (
STZ
)‐treated mice (
n
= 6/group) by label‐free shotgun mass spectrometry (
MS
) and targeted
MS
. Unsupervised and supervised multivariate analyses are followed by one‐way
ANOVA
. Shotgun
MS
data of vehicle and liraglutide‐treated mouse groups are separated in the supervised multivariate analysis and separation is also achieved in the subsequent unsupervised multivariate analysis using targeted
MS
data. The mouse group receiving the
GLP
‐1R agonist liraglutide has increased protein abundances of glutathione peroxidase‐3 (
GPX
3) and catalase (
CATA
) while the abundances of neuroplastin (
NPTN
) and bifunctional glutamate/proline–
tRNA
ligase (
SYEP
) are decreased compared to the
STZ
vehicle mice. The data suggest that
GLP
‐1R agonism mainly influences abundances of structurally involved proteins and proteins involved in oxidative stress responses in the
STZ
mouse kidney. The changes could be direct effects of
GLP
‐1R agonism in the kidneys or indirectly caused by a systemic response to
GLP
‐1R activation.